Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Griffith

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|May 23, 2018
<i>In Vivo</i> and <i>In Vitro</i> Effects of a ClpP-Activating Antibiotic against Vancomycin-Resistant EnterococciAutumn Brown Gandt, Elizabeth C Griffith, Ida M Lister, et al.
Frontiers in Microbiology|August 2, 2018
The Structural and Functional Basis for Recurring Sulfa Drug Resistance Mutations in <i>Staphylococcus aureus</i> Dihydropteroate SynthaseElizabeth C Griffith, Miranda J Wallace, Yinan Wu, et al.
Journal of Medicinal Chemistry|June 13, 2019
De Novo Design of Boron-Based Peptidomimetics as Potent Inhibitors of Human ClpP in the Presence of Human ClpXJoanne Tan, Julie J Grouleff, Yulia Jitkova, et al.
ACS Infectious Diseases|January 20, 2021
The Discovery and Development of Thienopyrimidines as Inhibitors of <i>Helicobacter pylori</i> That Act through Inhibition of the Respiratory Complex IAlex K Mugengana, Nicole A Vita, Autumn Brown Gandt, et al.
ACS Infectious Diseases|December 31, 2019
Discovery and Characterization of the Antimetabolite Action of Thioacetamide-Linked 1,2,3-Triazoles as Disruptors of Cysteine Biosynthesis in Gram-Negative BacteriaMiranda J Wallace, Suresh Dharuman, Dinesh M Fernando, et al.
Nature Communications|October 2, 2020
Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligasesSeung Wook Yang, Xin Huang, Wenwei Lin, et al.
ACS Infectious Diseases|October 8, 2019
Ureadepsipeptides as ClpP ActivatorsElizabeth C Griffith, Ying Zhao, Aman P Singh, et al.
Journal of Medicinal Chemistry|January 10, 2022
A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical ProbesHuarui Cui, Anand Divakaran, Zachariah J Hoell, et al.
BMJ Open|November 9, 2019
CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested studyVerinder Singh Sidhu, Steven E Graves, Rachelle Buchbinder, et al.
Nature Microbiology|October 31, 2025
Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessusGregory A Phelps, Sinem Kurt, Alexander R Jenner, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|May 23, 2018
<i>In Vivo</i> and <i>In Vitro</i> Effects of a ClpP-Activating Antibiotic against Vancomycin-Resistant EnterococciAutumn Brown Gandt, Elizabeth C Griffith, Ida M Lister, et al.
Frontiers in Microbiology|August 2, 2018
The Structural and Functional Basis for Recurring Sulfa Drug Resistance Mutations in <i>Staphylococcus aureus</i> Dihydropteroate SynthaseElizabeth C Griffith, Miranda J Wallace, Yinan Wu, et al.
Journal of Medicinal Chemistry|June 13, 2019
De Novo Design of Boron-Based Peptidomimetics as Potent Inhibitors of Human ClpP in the Presence of Human ClpXJoanne Tan, Julie J Grouleff, Yulia Jitkova, et al.
ACS Infectious Diseases|January 20, 2021
The Discovery and Development of Thienopyrimidines as Inhibitors of <i>Helicobacter pylori</i> That Act through Inhibition of the Respiratory Complex IAlex K Mugengana, Nicole A Vita, Autumn Brown Gandt, et al.
ACS Infectious Diseases|December 31, 2019
Discovery and Characterization of the Antimetabolite Action of Thioacetamide-Linked 1,2,3-Triazoles as Disruptors of Cysteine Biosynthesis in Gram-Negative BacteriaMiranda J Wallace, Suresh Dharuman, Dinesh M Fernando, et al.
Nature Communications|October 2, 2020
Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligasesSeung Wook Yang, Xin Huang, Wenwei Lin, et al.
ACS Infectious Diseases|October 8, 2019
Ureadepsipeptides as ClpP ActivatorsElizabeth C Griffith, Ying Zhao, Aman P Singh, et al.
Journal of Medicinal Chemistry|January 10, 2022
A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical ProbesHuarui Cui, Anand Divakaran, Zachariah J Hoell, et al.
BMJ Open|November 9, 2019
CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested studyVerinder Singh Sidhu, Steven E Graves, Rachelle Buchbinder, et al.
Nature Microbiology|October 31, 2025
Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessusGregory A Phelps, Sinem Kurt, Alexander R Jenner, et al.
Pageof 4